Skip to main content
    • Aa
    • Aa
  • Access
  • Cited by 19
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Gao, Keming Kemp, David E. Wu, Renrong and Calabrese, Joseph R. 2015. Psychiatry.

    Hay, Phillipa J. and Claudino, Angélica M. 2015. The Wiley Handbook of Eating Disorders.

    Malhi, Gin S 2015. Lithium therapy in bipolar disorder: a balancing act?. The Lancet, Vol. 386, Issue. 9992, p. 415.

    Nascimento, Camila Kim, Helena Kyunghee Young, L. Trevor Mendonça, Karina Martinez Grinberg, Lea Tenenholz Lafer, Beny and Andreazza, Ana Cristina 2015. Glutathione-mediated effects of lithium in decreasing protein oxidation induced by mitochondrial complex I dysfunction. Journal of Neural Transmission, Vol. 122, Issue. 6, p. 741.

    Park, Sung Woo Lee, Jung Goo Seo, Mi Kyoung Cho, Hye Yeon Lee, Chan Hong Lee, Ji Heon Lee, Bong Ju Baek, Jun Hyung Seol, Wongi and Kim, Young Hoon 2015. Effects of mood-stabilizing drugs on dendritic outgrowth and synaptic protein levels in primary hippocampal neurons. Bipolar Disorders, Vol. 17, Issue. 3, p. 278.

    Phelps, James R. Siemers, Susan V. and El-Mallakh, Rif S. 2013. The ketogenic diet for type II bipolar disorder. Neurocase, Vol. 19, Issue. 5, p. 423.

    Müller-Oerlinghausen, B. 2012. Sind atypische Antipsychotika Mittel erster Wahl bei bipolaren Störungen? Kontra. Der Nervenarzt, Vol. 83, Issue. 9, p. 1191.

    2012. A Handbook for the Assessment of Children's Behaviours.

    Malhi, Gin S Tanious, Michelle and Gershon, Samuel 2011. The lithiumeter: a measured approach. Bipolar Disorders, Vol. 13, Issue. 3, p. 219.

    Malhi, Gin S Chengappa, KN Roy Gershon, Samuel and Ghaemi, Seyyed N 2011. Atypical mood stabilizers: a new role for neuroleptics?. Bipolar Disorders, Vol. 13, Issue. 7-8, p. 583.

    Malhi, Gin S. and Tanious, Michelle 2011. Optimal Frequency of Lithium Administration in the Treatment of Bipolar Disorder. CNS Drugs, Vol. 25, Issue. 4, p. 289.

    Safer, Daniel J 2010. Mood swing and mood stabilizer: how specific are these terms?. Bipolar Disorders, Vol. 12, Issue. 7, p. 685.

    Ceron-Litvoc, Daniela Soares, Bernardo Garcia Geddes, John Litvoc, Julio and Lima, Mauricio Silva de 2009. Comparison of carbamazepine and lithium in treatment of bipolar disorder: A systematic review of randomized controlled trials. Human Psychopharmacology: Clinical and Experimental, Vol. 24, Issue. 1, p. 19.

    Gershon, Samuel Chengappa, KN Roy and Malhi, Gin S 2009. Lithium specificity in bipolar illness: a classic agent for the classic disorder. Bipolar Disorders, Vol. 11, p. 34.

    Malhi, Gin S. Adams, Danielle Cahill, Catherine M. Dodd, Seetal and Berk, Michael 2009. The Management of Individuals with Bipolar Disorder. Drugs, Vol. 69, Issue. 15, p. 2063.

    Nassir Ghaemi, S 2008. Why antidepressants are not antidepressants: STEP-BD, STAR*D, and the return of neurotic depression. Bipolar Disorders, Vol. 10, Issue. 8, p. 957.

    Sachdev, Perminder S. 2008. Is Kleine-Levin syndrome a variant of bipolar disorder? An hypothesis. Acta Neuropsychiatrica, Vol. 20, Issue. 04, p. 177.

    Malhi, Gin S. and Yatham, Lakshmi N. 2007. Mania matters!. Acta Psychiatrica Scandinavica, Vol. 116, Issue. s434, p. 1.

    Malhi, G. S. and Lagopoulos, J. 2007. Making sense of neuroimaging in psychiatry. Acta Psychiatrica Scandinavica, p. 071120024945004.


What is a mood stabilizer?

  • GUY M. GOODWIN (a1) and GIN S. MALHI (a2)
  • DOI:
  • Published online: 13 December 2006

The concept of mood stability is attractive to both patients and clinicians alike, and hence the term ‘mood stabilizer’ has widespread currency. However, its worldwide acceptance and use in clinical practice is at odds with the absence of official recognition by regulatory authorities. The ideal mood stabilizer is said to have efficacy in the treatment of acute manic and depressive episodes, and also be effective in the prevention of recurrences. However, in reality, few drugs with perhaps the exception of lithium, come close to this gold standard; yet many agents aspire to the title, and some have arguably achieved it prematurely. It is, therefore, important to reconsider the definition of a mood stabilizer and critically review which agents, if any, satisfy the necessary eligibility requirements by reference to reasonable criteria and comparator data. The term mood stabilizer is an important label. It needs to be applied judiciously because it confers clinical credibility and qualifies long-term use in maintenance and prophylaxis. It is also important with respect to developing guidelines for treatment and the further development of novel agents. Most importantly, however, it is a term that is innately appealing because of what it promises: for this reason alone it should encompass only those agents that can deliver.

    • Send article to Kindle

      To send this article to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

      Note you can select to send to either the or variations. ‘’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      What is a mood stabilizer?
      Available formats
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about sending content to Dropbox.

      What is a mood stabilizer?
      Available formats
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about sending content to Google Drive.

      What is a mood stabilizer?
      Available formats
Corresponding author
University of Sydney, Head, Academic Discipline of Psychological Medicine, Royal North Shore Hospital, St Leonards, Sydney, NSW 2065, Australia. (Email:
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Psychological Medicine
  • ISSN: 0033-2917
  • EISSN: 1469-8978
  • URL: /core/journals/psychological-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *